NCT03355157 2024-10-01
PADMA
GBG Forschungs GmbH
Phase 4 Completed
Clinical Trials
3 trialsNCT05131841 2021-11-23
Cipterbin Combined With Vinorelbine in the Treatment of HER2-positive MBC
Zhejiang Cancer Hospital
Phase 4 Unknown
NCT03270007 2020-10-28
Research of Intensive Treatment in Hormone Receptor<10% and Human Epidermal Growth Factor Receptor-2 Negative Breast Cancer Patients With Positive Lymph Node Residual Disease After Neoadjuvant Chemotherapy
Peking University
Phase 4 Unknown